Currently the price is 10,53$, Harrow Health Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Andrew R. Boll (Chief Financial Officer & Secretary), Larry M. Dillaha (Chief Medical Officer), Mark L. Baum (Chairman & Chief Executive Officer) and its address is 102 WOODMONT BOULEVARD SUITE 610, NASHVILLE, Tennessee, 37205, United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 10,06$ - 10,71$, with a percentage difference of 10,39$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].